Vitamin C Infusion Benefits 2026: What the Science Shows

Vitamin C infusion delivers ascorbic acid or sodium ascorbate directly into the bloodstream, bypassing the gut’s absorption controls and achieving blood levels 10 to 100 times higher than any oral supplement can produce. At these concentrations, vitamin C behaves differently inside the body. At normal dietary levels, it functions as an antioxidant and enzyme cofactor. At the millimolar concentrations achieved by IV infusion, it generates hydrogen peroxide selectively in tissues and acts as a pro-oxidant against certain types of cells.

The NIH Office of Dietary Supplements sets the Recommended Dietary Allowance for oral vitamin C at 75 to 90 milligrams per day. The Tolerable Upper Intake Level is 2,000 milligrams. A typical vitamin C IV infusion contains 10 to 50 grams, which is 100 to 500 times the RDA and 5 to 25 times the oral upper limit. At an oral dose of 1,000 milligrams, peak plasma vitamin C reaches roughly 70 to 80 micromoles per liter. A 50-gram IV infusion can push plasma levels above 10,000 micromoles per liter, a concentration at which extracellular ascorbate spontaneously generates hydrogen peroxide that can damage certain cell types.

See also: Vitamin C Infusion Benefits: What the 2026 Science Shows

This article explains exactly how IV vitamin C works pharmacokinetically, which benefits have genuine clinical trial support, which claims are still unproven, what the risks are, and who should not go near a vitamin C drip. Every claim is sourced to named studies, named organizations, and the published medical literature available as of 2026.

Vitamin C Infusion Benefits at a Glance

Vitamin C infusion is studied for three primary evidence-backed purposes: achieving pharmacologic plasma concentrations impossible with oral intake, generating localized hydrogen peroxide as a potential anti-tumor mechanism in cancer research, and rapidly correcting severe vitamin C depletion in critically ill patients. The benefits marketed by wellness clinics, including improved energy, enhanced immune function, brighter skin, and faster workout recovery, have less rigorous clinical support and vary in evidence quality from moderate to anecdotal.

The table below maps each commonly claimed benefit of vitamin C infusion to its mechanism, the strength of the human evidence, and the appropriate level of skepticism.

Evidence strength: Well-established means multiple consistent human studies with IV-specific data. Moderate means some RCTs exist or strong oral data with biological rationale for IV. Emerging means phase I/II trials exist. Weak means primarily anecdotal or uncontrolled data.

How Does IV Vitamin C Work? The Pharmacokinetic Difference

IV vitamin C works by bypassing the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, that tightly regulate how much vitamin C enters the bloodstream from the gut. Oral vitamin C absorption is saturable. At doses above 200 to 300 milligrams, the transporters are saturated and additional vitamin C is excreted in urine. IV administration bypasses this gatekeeping entirely and delivers ascorbate directly into the plasma, producing concentrations proportional to the dose infused.

The pharmacokinetic numbers explain the entire clinical rationale for IV vitamin C. An oral dose of 200 milligrams produces a peak plasma concentration of roughly 40 to 60 micromoles per liter. An oral dose of 1,000 milligrams pushes peak levels to roughly 70 to 80 micromoles per liter, and going higher orally produces diminishing returns. A 10-gram IV infusion produces peak levels of approximately 1,000 to 1,500 micromoles per liter. A 50-gram IV infusion can produce levels above 10,000 micromoles per liter. The NIH Office of Dietary Supplements confirms that oral vitamin C bioavailability declines sharply above 200 milligrams per dose. The IV route changes the pharmacology entirely.

At plasma concentrations above roughly 1,000 micromoles per liter, ascorbate begins to function as a pro-oxidant rather than an antioxidant in the extracellular fluid. It donates electrons to transition metals like iron and copper, generating hydrogen peroxide. This hydrogen peroxide is then converted to water by catalase in most cells. But certain cell types, including some cancer cells, have low catalase activity. In these cells, hydrogen peroxide accumulates and causes oxidative damage that triggers cell death. This is the mechanism studied in cancer research, and it only occurs at concentrations unattainable through oral intake.

Think of oral vitamin C like filling a bathtub with the drain partially open. You can only fill it so far before the water going in equals the water going out. IV vitamin C is like hooking a fire hose directly to the tub and bypassing the faucet entirely. The tub fills to levels the faucet could never achieve.

Vitamin C Infusion vs Oral Absorption: Why the Method Matters

Oral vitamin C and IV vitamin C are pharmacologically different interventions despite using the same molecule. Oral vitamin C is a micronutrient that functions within the body’s tightly regulated homeostatic range. IV vitamin C is a pharmacologic agent that temporarily overwhelms homeostasis to achieve tissue concentrations associated with different biological effects. Comparing them directly is like comparing a bicycle to a motorcycle. Both move you forward. The speed, the risks, and the regulations are completely different.

The bioavailability of oral vitamin C peaks at about 200 milligrams per dose. At this dose, roughly 80 to 90 percent is absorbed. At 1,000 milligrams, absorption drops below 50 percent. At higher oral doses, the unabsorbed fraction draws water into the colon, causing the osmotic diarrhea that limits oral vitamin C tolerance. This is why the oral UL is set at 2,000 milligrams. It is not because vitamin C is toxic at that dose. It is because doses above that reliably cause gastrointestinal distress.

IV vitamin C has 100 percent bioavailability by definition. The entire dose enters the bloodstream. There is no gut absorption step, no transporter saturation, and no osmotic diarrhea. The only limit on IV dosing is the body’s ability to clear ascorbate through the kidneys and metabolize it in tissues. At doses above 50 grams, renal clearance is overwhelmed and plasma concentrations rise to levels that generate extracellular hydrogen peroxide. This is the pharmacologic window that cancer researchers are investigating.

The table below compares the two routes of administration across key parameters.

Key Takeaway: Oral vitamin C is a nutrient. IV vitamin C at high doses is a pharmacologic intervention. The same molecule does different things depending on how much of it reaches your tissues and how it gets there. The route of administration changes everything.

High-Dose Vitamin C Mechanism: From Antioxidant to Pro-Oxidant

At dietary and standard supplemental doses, vitamin C functions as an antioxidant by donating electrons to neutralize reactive oxygen species and by regenerating vitamin E from its oxidized form. At the millimolar plasma concentrations achieved by high-dose IV infusion, vitamin C switches roles and acts as a pro-oxidant by reducing transition metals and generating hydrogen peroxide. This concentration-dependent duality is the most important concept in understanding IV vitamin C research.

The antioxidant function operates at plasma concentrations below roughly 200 micromoles per liter, which is the range achievable through diet and oral supplementation. At these concentrations, ascorbate donates one electron to neutralize free radicals including superoxide, hydroxyl radical, and singlet oxygen. It also regenerates alpha-tocopherol from the alpha-tocopheroxyl radical, restoring vitamin E’s antioxidant capacity. These reactions are well characterized and non-controversial.

The pro-oxidant function emerges at plasma concentrations above roughly 1,000 micromoles per liter, which requires IV administration. At these concentrations, ascorbate reduces ferric iron to ferrous iron, which then donates an electron to oxygen, producing superoxide. Superoxide dismutates to hydrogen peroxide. In most cells, catalase and glutathione peroxidase convert hydrogen peroxide to water and oxygen, preventing damage. In cells with low catalase activity, including some cancer cell lines, hydrogen peroxide accumulates and causes oxidative damage to DNA, proteins, and lipids, leading to cell death.

A 2023 study published in Cancer Research demonstrated that ascorbate-induced hydrogen peroxide generation is selectively toxic to colorectal cancer cells with KRAS or BRAF mutations. These mutations upregulate the GLUT1 glucose transporter, which also transports the oxidized form of vitamin C, dehydroascorbic acid, into cells. Once inside, dehydroascorbic acid is reduced back to ascorbic acid at the expense of glutathione, depleting the cell’s antioxidant reserves and making it vulnerable to the hydrogen peroxide generated extracellularly by ascorbate. This mechanism is specific to IV concentrations. Oral vitamin C cannot achieve the extracellular ascorbate levels required.

Vitamin C Infusion for Immune Support: What the Research Says

Vitamin C is concentrated in immune cells, where it supports neutrophil chemotaxis, phagocytosis, and the oxidative burst that kills pathogens. The immune cell function of vitamin C is well established at dietary intake levels. The evidence that high-dose IV vitamin C provides additional immune support beyond what adequate oral intake provides is limited and largely anecdotal.

Neutrophils concentrate vitamin C to levels 50 to 100 times higher than plasma. They use ascorbate to protect themselves from the reactive oxygen species they produce during the oxidative burst that kills bacteria. Lymphocytes also concentrate vitamin C, though to a lesser degree. When vitamin C intake is inadequate, immune cell function declines measurably. The NIH Office of Dietary Supplements notes that vitamin C deficiency impairs immune function and increases susceptibility to infections. Correction of deficiency restores normal immune function.

The question for IV vitamin C is whether pharmacologic doses provide immune benefit beyond what adequate dietary intake provides. The evidence is thin. A 2022 systematic review published in Nutrients examined clinical trials of IV vitamin C for infection and found that most trials were small, many were uncontrolled, and the results were inconsistent. High-dose IV vitamin C did not prevent infections in intensive care unit patients in the largest trials. It modestly reduced the duration of common cold symptoms in some outpatient studies, but the effect size was similar to oral vitamin C.

A person with adequate dietary vitamin C intake and normal immune function is unlikely to experience a measurable immune benefit from IV vitamin C infusion. A person with vitamin C deficiency, which is rare in developed countries but occurs in people with very poor diets, malabsorption disorders, or severe illness, would benefit from vitamin C repletion. Whether that repletion requires IV administration depends on the severity of the deficiency and the patient’s ability to take oral supplements. In most cases, oral vitamin C is sufficient.

Vitamin C IV for Cancer: The Current Evidence

High-dose IV vitamin C is being investigated as an adjunct to conventional cancer treatment, and the current evidence from phase I and phase II clinical trials suggests it is generally safe under medical supervision and may improve quality of life and reduce treatment-related side effects in some patients. The evidence that IV vitamin C directly treats cancer by shrinking tumors is not established, and the National Cancer Institute does not endorse IV vitamin C as a cancer treatment.

The clinical research on IV vitamin C and cancer divides into two categories. The first is quality-of-life research. Phase I and II trials published in the Journal of Clinical Oncology and Nutrients have found that IV vitamin C at doses of 50 to 100 grams two to three times per week, administered alongside conventional chemotherapy or radiation, was associated with reduced fatigue, nausea, and pain in patients with advanced cancer compared to historical controls. These were not randomized placebo-controlled trials, and the placebo effect from receiving an IV treatment in a clinical setting is real. The quality-of-life signal is promising but not definitive.

The second category is tumor response research. Laboratory studies have demonstrated that pharmacologic ascorbate concentrations kill cancer cells selectively through hydrogen peroxide generation, as described in the mechanism section. Animal studies have shown tumor growth delay. Human phase I trials have established the safety of IV ascorbate up to 1.5 grams per kilogram of body weight. Phase II trials examining tumor response are ongoing. A 2024 phase II trial in pancreatic cancer patients combining IV vitamin C with gemcitabine and nab-paclitaxel showed a modest improvement in progression-free survival compared to historical controls, but the trial was not randomized.

The American Cancer Society states that high-dose vitamin C has been studied as a cancer treatment, that the evidence is not conclusive, and that patients should discuss any complementary therapy with their oncologist before starting treatment. An oncologist can review the specific chemotherapy agents a patient is receiving because vitamin C can theoretically interact with certain drugs, including some that rely on oxidative stress for their mechanism of action.

Key Takeaway: IV vitamin C for cancer is an active area of legitimate research. The quality-of-life data is promising. The tumor-shrinking data is not yet definitive. It is an adjunct under investigation, not a proven treatment, and should only be used under an oncologist’s supervision.

You might also find this useful: Vitamin C IV Benefits 2026: What the Science Actually Shows

Vitamin C Infusion for Skin Health and Collagen Production

Vitamin C is required for collagen synthesis as a cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase, which stabilize and cross-link collagen molecules. This mechanism is well established. The evidence that high-dose IV vitamin C improves skin appearance beyond what adequate dietary intake and topical application provide is not established.

Collagen is the structural protein of skin, and vitamin C is essential for its production. Without vitamin C, collagen synthesis fails and skin integrity deteriorates. This is the mechanism behind the skin manifestations of scurvy. Adequate dietary vitamin C intake supports normal collagen production. The NIH Office of Dietary Supplements confirms that vitamin C is necessary for collagen synthesis. There is no debate about the mechanism.

The question is whether delivering vitamin C at IV doses far above the levels that saturate collagen-synthesizing enzymes provides additional benefit. Prolyl hydroxylase and lysyl hydroxylase are saturated at vitamin C concentrations well within the range achievable by oral intake. Flooding the system with additional vitamin C beyond enzyme saturation does not increase collagen production. The enzymes are already working at maximum capacity with adequate dietary intake.

The skin benefits marketed by IV drip lounges typically combine vitamin C with glutathione, B vitamins, and fluids. Any visible improvement in skin appearance after an infusion is more likely attributable to the hydration from the IV fluid volume and the placebo response than to a collagen-specific vitamin C effect. The American Academy of Dermatology does not recommend IV vitamin C for skin health. Topical vitamin C as L-ascorbic acid in properly formulated serums has stronger evidence for skin benefits than IV vitamin C.

Vitamin C Infusion for Fatigue and Recovery

Vitamin C is required for the synthesis of carnitine, which transports fatty acids into mitochondria for energy production, and for the synthesis of norepinephrine, a neurotransmitter involved in alertness and energy. Vitamin C deficiency causes fatigue as a symptom of scurvy. The evidence that IV vitamin C reduces fatigue in people with adequate vitamin C status is weak and largely anecdotal.

The mechanism linking vitamin C to energy metabolism is real. Carnitine is synthesized from lysine and methionine in a reaction that requires ascorbate as a cofactor. Without vitamin C, carnitine synthesis declines and fatty acid transport into mitochondria is impaired. This reduces the availability of fat for energy production. Norepinephrine synthesis also requires ascorbate. Norepinephrine is involved in the fight-or-flight response and contributes to alertness and mental energy.

When a person with vitamin C deficiency receives vitamin C, whether orally or IV, fatigue improves as carnitine and norepinephrine synthesis normalize. This is well documented. The question is whether a person with adequate vitamin C status experiences additional energy benefit from high-dose IV vitamin C. The clinical evidence does not show this. Small uncontrolled studies of IV vitamin C for chronic fatigue have reported subjective improvement, but the lack of blinding and placebo control makes the results uninterpretable.

The placebo effect of receiving an IV infusion in a clinical setting is powerful. The ritual of the drip, the attention from staff, the expectation of benefit, and the hydration from the IV fluid all contribute to feeling better afterward. This does not mean the benefit is fake. It means the benefit may not be coming from the vitamin C molecule.

Vitamin C Infusion Side Effects: Real Risks to Know

Vitamin C infusions are generally well tolerated at doses up to 1.5 grams per kilogram of body weight, but side effects include thirst, nausea, headache, and dizziness during or immediately after the infusion. More serious risks include oxalate kidney stone formation from the metabolism of high-dose ascorbate and life-threatening hemolysis in people with undiagnosed G6PD deficiency.

The common side effects of thirst, nausea, and headache are usually mild and resolve when the infusion is slowed or stopped. They are related to the osmotic load of the concentrated ascorbate solution and the rapid shift in plasma osmolality. Drinking water before and after the infusion can reduce these symptoms. Dizziness may reflect a drop in blood pressure or blood sugar. Eating a normal meal before an infusion and staying hydrated reduces this risk.

The long-term risk of oxalate kidney stones is real and underappreciated in wellness clinic marketing. Vitamin C is metabolized to oxalate in the body. At dietary and standard supplemental doses, the amount of oxalate produced is small and handled by the kidneys without issue. At high IV doses, oxalate production increases proportionally. A single 50-gram IV dose of vitamin C can produce several hundred milligrams of oxalate, which is excreted in the urine. High urinary oxalate concentrations increase the risk of calcium oxalate stone formation, particularly in people with a history of stones or low fluid intake.

The table below summarizes the known side effects and risks of IV vitamin C.

Vitamin C Infusion and Kidney Stones: The Oxalate Concern

Vitamin C is metabolized to oxalate in the body, and high-dose IV vitamin C can significantly increase urinary oxalate excretion, raising the risk of calcium oxalate kidney stones. A person with a history of kidney stones, chronic kidney disease, or a family history of oxalate stones should not receive high-dose IV vitamin C without discussing the risk with a nephrologist.

Oxalate is a natural end product of ascorbate metabolism. At dietary vitamin C intakes, roughly 30 to 40 milligrams of oxalate are produced daily from vitamin C metabolism out of a total daily oxalate load of 100 to 300 milligrams from combined dietary sources and endogenous production. At a 50-gram IV vitamin C dose, the oxalate production from ascorbate metabolism alone can exceed 300 milligrams from a single infusion.

The kidneys filter oxalate from the blood and excrete it in urine. When urinary oxalate concentration exceeds the solubility threshold, calcium oxalate crystals form. These crystals can aggregate into stones. Dehydration concentrates the urine and increases stone risk. People with a history of calcium oxalate stones, hyperoxaluria, or conditions that increase stone risk such as inflammatory bowel disease or gastric bypass surgery are at particularly high risk.

A nephrologist evaluating a patient for recurrent kidney stones would ask about vitamin C supplementation. The NIH Office of Dietary Supplements notes that high-dose vitamin C supplementation is associated with an increased risk of kidney stones in men. The evidence is strongest for oral supplementation above 1,000 milligrams daily. The IV data is less extensive but the oxalate mechanism is the same. A nephrologist would likely advise a patient with stone history to avoid high-dose IV vitamin C.

Who Should Not Get a Vitamin C Infusion

Several medical conditions are absolute or relative contraindications to high-dose IV vitamin C infusion. The most critical is glucose-6-phosphate dehydrogenase deficiency. Other contraindications include a history of oxalate kidney stones, renal insufficiency, hemochromatosis, and pregnancy.

People with G6PD deficiency cannot receive high-dose vitamin C infusions because ascorbate can trigger severe hemolysis, a condition in which red blood cells rupture. This is a medical emergency that can be fatal. G6PD deficiency is an inherited enzyme deficiency that affects approximately 400 million people worldwide, most commonly in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent. G6PD testing should be performed before initiating high-dose IV vitamin C infusions.

People with a history of calcium oxalate kidney stones should avoid high-dose IV vitamin C because of the oxalate production described in the previous section. People with chronic kidney disease or renal insufficiency should avoid it because the kidneys are responsible for clearing both ascorbate and oxalate, and impaired kidney function increases the risk of toxicity.

People with hemochromatosis or other iron overload disorders should avoid high-dose vitamin C because vitamin C enhances iron absorption and can mobilize stored iron, potentially causing oxidative damage from free iron. People who are pregnant or breastfeeding should avoid elective IV vitamin C because the safety of high-dose ascorbate in pregnancy has not been established.

G6PD Deficiency and Vitamin C IV: A Life-Threatening Risk

High-dose intravenous vitamin C can cause acute hemolysis in people with glucose-6-phosphate dehydrogenase deficiency by generating oxidative stress that red blood cells lacking G6PD cannot neutralize. This is an absolute contraindication. G6PD screening is essential before any high-dose IV vitamin C infusion.

G6PD is an enzyme in the pentose phosphate pathway that produces NADPH, which maintains glutathione in its reduced form. Glutathione is the primary intracellular antioxidant that protects red blood cells from oxidative damage. When G6PD is deficient, red blood cells cannot regenerate reduced glutathione, and they are vulnerable to oxidative hemolysis. High-dose vitamin C at pharmacologic concentrations generates hydrogen peroxide extracellularly. In G6PD-deficient red blood cells, this oxidative stress overwhelms the depleted antioxidant defenses, hemoglobin denatures, and the cells rupture.

The hemolytic crisis presents with sudden onset of fatigue, pallor, jaundice, dark urine from hemoglobinuria, and rapid heart rate. It can progress to severe anemia, kidney failure, and death if not recognized and treated promptly. Case reports of IV vitamin C-induced hemolysis in G6PD-deficient patients have been published in the medical literature, and the NIH Office of Dietary Supplements warns against high-dose IV vitamin C in G6PD deficiency.

The test for G6PD deficiency is a simple blood test. It costs a fraction of what a single IV vitamin C session costs. Any clinic offering high-dose IV vitamin C without requiring G6PD screening is not practicing safely. A person considering IV vitamin C should ask whether G6PD testing is required and should not proceed without it.

Also worth exploring: Vitamin D3 K2 Benefits: The Complete Evidence Breakdown for 2026

Key Takeaway: G6PD deficiency makes high-dose vitamin C IV potentially fatal. The screening test is cheap and essential. Do not accept an infusion from any provider that does not require G6PD testing before high-dose therapy.

Vitamin C IV Clinical Trials: Evidence Quality Overview

The clinical trial evidence for IV vitamin C is strongest for safety and pharmacokinetics, moderate for quality of life as a cancer adjunct, and weak for most wellness claims including fatigue reduction, immune enhancement, athletic recovery, and skin rejuvenation. The cancer research is genuine and ongoing. The wellness marketing has outrun the evidence by a wide margin.

The table below summarizes the evidence quality for each category of IV vitamin C use.

RCT = randomized controlled trial. Evidence quality assessment based on number, size, blinding, and consistency of available trials as of 2026.

What to Expect at a Vitamin C IV Session

A typical vitamin C IV session at a wellness clinic involves placement of a peripheral IV catheter, infusion of a solution containing vitamin C and often other additives such as B vitamins, magnesium, glutathione, and fluids over 30 to 120 minutes, and post-infusion monitoring. The experience is similar to receiving IV fluids in a medical setting.

The infusion solution is typically compounded by a pharmacy and may contain 10 to 50 grams of vitamin C as sodium ascorbate or ascorbic acid, often buffered to reduce acidity. The solution volume is 500 to 1,000 milliliters. Add-on ingredients like glutathione, B complex vitamins, zinc, and magnesium are common and increase the cost. The evidence for these add-ons is not stronger than the evidence for vitamin C alone.

During the infusion, the patient sits in a reclining chair. The drip rate is adjusted based on tolerance. Some patients feel a warming sensation or a mild metallic taste during the infusion. These are common and not dangerous. Thirst is common. Drinking water before and after reduces thirst and supports oxalate clearance.

After the infusion, the IV is removed and the patient can leave immediately. Some patients report feeling energized or clear-headed. Some feel tired. Hydration from the IV fluid likely accounts for part of the post-infusion sensation. The vitamin C is cleared from the blood within hours. The subjective effects may last hours to a day.

Vitamin C IV Cost and What You’re Actually Getting

Vitamin C IV infusions at wellness clinics cost between $100 and $300 per session, with some high-end clinics charging $400 or more for premium formulations with additional vitamins and antioxidants. Insurance does not cover IV vitamin C for wellness purposes. The cost is entirely out of pocket.

What the patient is buying is a combination of the vitamin C, the IV fluids, the clinic overhead, and the experience. A 50-gram vial of injectable ascorbic acid costs the compounding pharmacy a few dollars. The cost to the patient reflects the clinic’s equipment, staffing, and profit margin, not the cost of the vitamin C.

Add-on ingredients increase the price. A basic vitamin C drip might cost $150. A “Myers’ cocktail” with vitamin C, B vitamins, magnesium, and calcium might cost $200. A “premium” drip with glutathione, vitamin C, and additional antioxidants might cost $300 or more. The evidence that the add-ons provide additional benefit is not stronger than the evidence for vitamin C alone.

For a person considering regular IV vitamin C for wellness, the annual cost at one session per month ranges from $1,200 to $4,800. For a person considering twice-weekly sessions, the annual cost can exceed $20,000. A registered dietitian evaluating the cost-effectiveness of IV vitamin C for a wellness client would note that the same money could purchase a year’s supply of high-quality whole foods, a gym membership, and comprehensive health screening with money remaining. The evidence for those interventions is stronger.

Frequently Asked Questions About Vitamin C Infusion

What does a vitamin C infusion do for your body?

Vitamin C infusion delivers ascorbate directly into the bloodstream, bypassing gut absorption limits and achieving plasma concentrations 10 to 100 times higher than oral supplements can reach.
At these high concentrations, vitamin C generates hydrogen peroxide that can selectively damage certain cell types, a mechanism studied in cancer research.
At lower concentrations, it functions as an antioxidant and supports collagen synthesis, carnitine production, and immune cell function.

Is IV vitamin C better than taking vitamin C orally?

IV vitamin C is not universally better than oral. It achieves higher blood levels and is appropriate for specific investigational medical uses, particularly in cancer research.
For general health, immune support, and collagen synthesis, oral vitamin C at adequate dietary intake levels achieves the concentrations needed for enzyme saturation.
Oral vitamin C is safer, cheaper, and regulated as a dietary supplement with a well-characterized safety profile.

Does vitamin C IV therapy help with cancer?

High-dose IV vitamin C is being studied as an adjunct to conventional cancer treatment and has shown promise for improving quality of life in phase II clinical trials.
The evidence that IV vitamin C shrinks tumors or extends survival is not yet established.
It should only be used under an oncologist’s supervision and is not a replacement for conventional cancer treatment.

What are the side effects of vitamin C infusion?

Common side effects include thirst, nausea, headache, and dizziness during or shortly after the infusion.
Serious risks include oxalate kidney stones from ascorbate metabolism and life-threatening hemolysis in people with G6PD deficiency.
High-dose IV vitamin C can also interfere with blood glucose monitor readings.

Who should not get a vitamin C IV drip?

People with G6PD deficiency should never receive high-dose IV vitamin C due to the risk of fatal hemolysis.
People with a history of kidney stones, renal insufficiency, or hemochromatosis should avoid it.
Pregnant and breastfeeding individuals should not receive elective IV vitamin C due to lack of safety data.

How much does a vitamin C infusion cost?

Vitamin C IV infusions typically cost between $100 and $300 per session at wellness clinics.
Insurance does not cover vitamin C infusions for wellness or general health purposes.
The cost reflects clinic overhead and experience, not the cost of the vitamin C itself, which is inexpensive.

Vitamin C infusion is a pharmacologic tool with a specific mechanism, a growing body of research, and real risks. The pharmacokinetic rationale is sound. Bypassing gut absorption achieves blood levels that oral supplements cannot match. At those levels, vitamin C behaves differently inside the body. The cancer research is legitimate and ongoing. The quality-of-life data for cancer patients is promising. The wellness clinic claims about energy, immunity, and skin are built on mechanisms that do not require high-dose IV vitamin C and are not supported by IV-specific clinical trials.

If you’re considering IV vitamin C, ask about G6PD screening. Ask about your kidney stone risk. Ask what’s in the bag beyond vitamin C. Ask how many sessions you’ll need and what the total cost will be. If the clinic cannot answer those questions clearly, walk away. If you’re managing cancer, discuss it with your oncologist. If you’re looking for energy, collagen support, or immune function, oral vitamin C from food and standard supplements achieves the concentrations your enzymes need. The drip is not the only way to get vitamin C into your body. It’s the most expensive way, and it comes with risks that a bell pepper does not.

Along the same lines: Vitamin C IV Benefits: What 2026 Research Proves